Keloid or hypertrophic scar - The controversy: Review of the literature

被引:155
作者
Atiyeh, BS [1 ]
Costagliola, M
Hayek, SA
机构
[1] Amer Univ Beirut, Div Plast & Reconstruct Surg, Med Ctr, Beirut, Lebanon
[2] Univ Toulouse, Dept Plast Surg, Toulouse, France
关键词
keloid; hypertrophic scar; cutaneous scar; dermal tumor;
D O I
10.1097/01.sap.0000164538.72375.93
中图分类号
R61 [外科手术学];
学科分类号
摘要
Keloid and hypertrophic scars are 2 types of excessive scarring observed clinically that require different therapeutic approaches. The clinical course and physical appearance define keloids and hypertrophic scars as separate entities; however, they are often confused because of an apparent lack of morphologic differences. Nevertheless, clinical differences between hypertrophic scars and keloids have long been recognized by plastic surgeons and dermatologists. Yet, translating these differences into morphologic or biochemical distinctions has prompted much conflict in the literature. The present report is an attempt to clarify the longstanding controversy regarding these 2 similar yet separate and nonidentical entities by highlighting the reported points of differentiation as well as the similarities.
引用
收藏
页码:676 / 680
页数:5
相关论文
共 38 条
[1]   Enhanced expression of caspase-3 in hypertrophic scars and keloid: Induction of caspase-3 and apoptosis in keloid fibroblasts in vitro [J].
Akasaka, Y ;
Ishikawa, Y ;
Ono, I ;
Fujita, K ;
Masuda, T ;
Asuwa, N ;
Inuzuka, K ;
Kiguchi, H ;
Ishii, T .
LABORATORY INVESTIGATION, 2000, 80 (03) :345-357
[2]   Vascularization pattern in hypertrophic scars and keloids:: A stereological analysis [J].
Amadeu, T ;
Braune, A ;
Mandarim-de-Lacerda, C ;
Porto, LC ;
Desmoulière, A ;
Costa, A .
PATHOLOGY RESEARCH AND PRACTICE, 2003, 199 (07) :469-473
[3]   Fibrillin-1 and elastin are differentially expressed in hypertrophic scars and keloids [J].
Amadeu, TP ;
Braune, AS ;
Porto, LC ;
Desmoulière, A ;
Costa, AMA .
WOUND REPAIR AND REGENERATION, 2004, 12 (02) :169-174
[4]   Genetic susceptibility to keloid disease and hypertrophic scarring:: Transforming growth factor β1 common polymorphisms and plasma levels [J].
Bayat, A ;
Bock, O ;
Mrowietz, U ;
Ollier, WER ;
Ferguson, MWJ .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2003, 111 (02) :535-543
[5]   Genetic susceptibility to keloid disease and transforming growth factor β2 polymorphisms [J].
Bayat, A ;
Bock, O ;
Mrowietz, U ;
Ollier, WER ;
Ferguson, MWJ .
BRITISH JOURNAL OF PLASTIC SURGERY, 2002, 55 (04) :283-286
[6]  
BLACKBURN WR, 1966, ARCH PATHOL, V82, P65
[7]   Keloid-derived fibroblasts are refractory to Fas-mediated apoptosis and neutralization of autocrine transforming growth factor-β1 can abrogate this resistance [J].
Chodon, T ;
Sugihara, T ;
Igawa, HH ;
Funayama, E ;
Furukawa, H .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (05) :1661-1669
[8]   SURGICAL TREATMENT OF KELOIDS [J].
COSMAN, B ;
CRIKELAIR, GF ;
GAULIN, C ;
JU, DMC ;
LATTES, R .
PLASTIC AND RECONSTRUCTIVE SURGERY, 1961, 27 (04) :335-+
[9]   KELOIDS - A REVIEW OF THE LITERATURE [J].
DATUBOBROWN, DD .
BRITISH JOURNAL OF PLASTIC SURGERY, 1990, 43 (01) :70-77
[10]   Molecular characterization and expression of p63 isoforms in human keloids [J].
De Felice, B ;
Wilson, RR ;
Nacca, M ;
Ciarmiello, LF ;
Pinelli, C .
MOLECULAR GENETICS AND GENOMICS, 2004, 272 (01) :28-34